Adaptive Biotechnologies Corporation (ADPT)
NASDAQ · Healthcare
Adaptive Biotechnologies Corporation annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Adaptive Biotechnologies Corporation total liabilities for the quarter ending December 31, 2025 were 287.7M, a 14.59% decrease year-over-year.
- Adaptive Biotechnologies Corporation total liabilities for 2025 were 287.7M, a 14.59% decrease from 2024.
- Adaptive Biotechnologies Corporation total liabilities for 2024 were 336.9M, a 4.52% decrease from 2023.
- Adaptive Biotechnologies Corporation total liabilities for 2023 were 352.9M, a 10.10% decrease from 2022.
- Adaptive Biotechnologies Corporation total liabilities for 2022 were 392.5M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adaptive Biotechnologies Corporation Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $288 |
| 2024 | $337 |
| 2023 | $353 |
| 2022 | $393 |
| 2021 | $319 |
| 2020 | $373 |
| 2019 | $341 |
| 2018 | $30 |
| Adaptive Biotechnologies Corporation Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $288 |
| 2024-12-31 | $337 |
| 2023-12-31 | $353 |
| 2022-12-31 | $393 |
| 2021-12-31 | $319 |
| 2020-12-31 | $373 |
| 2019-12-31 | $341 |
| 2018-12-31 | $30 |
Adaptive Biotechnologies Corporation Total Liabilities — FAQ
Adaptive Biotechnologies Corporation (ADPT) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADPT's total liabilities history?
The chart and table above show Adaptive Biotechnologies Corporation's total liabilities by year and by quarter, including the growth rate.